Maine Family Planning fought the halting of Medicaid dollars in federal court, but it suffered a setback in August when a ...

Givinostat is an oral histone deacetylase (HDAC) inhibitor approved by the FDA in 2024 to treat Duchenne patients ages 6 years and older. Pathologic upregulation of HDAC occurs in DMD, leading to ...

The trial tested two doses of claseprubart -- 300 mg and 600 mg -- and its primary endpoint was safety. Secondary outcomes ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

If medical societies cling to models built for an independent-practice era, they risk fading into irrelevance. But if they ...

Johansson and team also found that longer use of hormonal contraceptives resulted in an increased breast cancer risk. Use of ...

Sen. Bill Cassidy, MD (R-La.), chair of the committee, applauded medical innovations of the last few decades including ...

Beyond the 4-week mark, both MG-ADL and Quantitative Myasthenia Gravis scores improved in the overall population and in all ...

PHOENIX -- An implantable autologous cell therapy led to higher remission rates compared with standard surgical care in ...

An investigational live attenuated vaccine led to protection against Salmonella enterica serovar Paratyphi A infection, ...

The percentage of physicians sponsored by the H-1B visa program, which allows U.S. employers to hire workers outside the ...